Medisyn Technologies, Inc. an emerging stage biotechnology company focused on discovering new treatments for cancer, infectious diseases and Alzheimer's disease.

Key investors include:

Atlas Capital Partners
AC Partners portfolio is focused on early stage and emerging growth companies that are in various areas of innovation. They do not specialize in a single market vertical, but instead look for entrepreneurs with a proven product that is post-revenue, on the verge of rapid growth, and possesses a defensible competitive advantage. They specifically seek opportunities where human capital can add significant value. Their portfolio reflects a personal mission to leave the world in a better place than it was found.





Sherpa Partners, LLC
Sherpa Partners, LLC is a Minneapolis-based venture capital firm focused on early-stage companies in the Upper Midwest. We have decades of personal experience in the high-altitude, rarified air of new enterprises. As experienced operational managers, we are investing time, energy and money to help Midwest-based emerging technology companies create the strategies, systems, infrastructure and management teams to become leaders in their markets.

Portage Capital
Portage Capital, run by Brad Lehrman and Beatrice Rothweiler, is a business and venture capital consulting firm specializing in emerging growth companies at critical stages of development.

StarTec Investments, LLC
StarTec Investments, LLC. is a private venture capital firm founded in 1998 by Joy J. Lindsay and Thomas J. McLeod, Sr. The primary investment focus of StarTec is early-stage technology companies located in Minnesota.

Proceeds from future financing will be used to increase the discovery and testing of promising lead drug candidates. Medisyn already has multiple patent-pending therapeutic compounds in its portfolio for license to pharmaceutical partners.

If you are interested in funding opportunities and learning more about Medisyn's technology, please contact us.